Post-NACT | Post-CRT | Evaluation | |||||||
---|---|---|---|---|---|---|---|---|---|
ADIPOQ | 1.15 | ACVR1 | 1.10 | IGFBP3 | 1.21 | ADIPOQ | 1.10 | GRN | 1.12 |
ANG | 1.21 | ADIPOQ | 1.10 | IGFBP7 | 1.12 | ANG | 1.11 | IGF2 | 1.21 |
IGFBP2 | 1.15 | ANG | 1.21 | IL1RAPL2 | 1.10 | ANGPT2 | 1.16 | IGFBP7 | 1.15 |
IL6ST | 1.12 | BMPR1A | 1.11 | IL27 | 1.12 | BDNF | 1.11 | IL1RAPL2 | 1.11 |
NCAM1 | 1.12 | CCL1 | 1.11 | IL6ST | 1.17 | BMPR1A | 1.18 | IL22 | 1.12 |
SAA1 | 1.15 | CCL11 | 1.12 | LBP | 1.16 | CCL11 | 1.14 | IL6ST | 1.12 |
TNFRSF11B | 1.34 | CCL22 | 1.13 | LEPR | 1.11 | CCR6 | 1.14 | LIFR | 1.12 |
 |  | CCR6 | 1.10 | PLAU | 1.12 | CD14 | 1.13 | MMP2 | 1.10 |
 |  | CD14 | 1.14 | RARRES2 | 1.12 | CSF1 | 1.19 | NGFB | 1.12 |
 |  | CSF1 | 1.22 | RELT | 1.11 | CTF1 | 1.12 | NTF4 | 1.13 |
 |  | EGFR | 1.11 | SAA1 | 1.27 | CXCR1 | 1.19 | RARRES2 | 1.23 |
 |  | ERBB2 | 1.20 | SIGLEC5 | 1.14 | CXCR5 | 1.11 | SIGLEC9 | 1.12 |
 |  | FLT3LG | 1.11 | SIGLEC9 | 1.13 | CXCR6 | 1.12 | SLC2A2 | 1.19 |
 |  | GCG | 1.13 | SLC2A2 | 1.13 | ERBB2 | 1.11 | THBS4 | 1.12 |
 |  | GRN | 1.16 | TGFBR1 | 1.11 | ERBB4 | 1.11 | TNFRSF11B | 1.16 |
 |  | IGF2 | 1.18 | THBS4 | 1.10 | FLT3LG | 1.12 |  |  |
 |  | IGFBP2 | 1.15 | TNFRSF11B | 1.65 |  |  |  |  |
LCN2 | 0.65 | CHRDL2 | 0.88 | PDGFA | 0.86 | CHRDL2 | 0.86 | PDGFA | 0.88 |
LTBP1 | 0.87 | CXCL2 | 0.88 | PDGFB | 0.89 | FGF13 | 0.84 | S100A12 | 0.84 |
MMP9 | 0.63 | FGF13 | 0.83 | PF4 | 0.85 | LCN2 | 0.84 | TMEFF2 | 0.89 |
 |  | LCN2 | 0.73 | PPBP | 0.83 | MMP9 | 0.74 |  |  |
 |  | LTBP1 | 0.80 | S100A12 | 0.85 |  |  |  |  |
 |  | MMP9 | 0.68 | THBS1 | 0.84 |  |  |  |  |